This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The University of Manchester. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: The Innovations of Stuart McRae Allan
Introduction
Stuart McRae Allan is a notable inventor based in Manchester, GB. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target specific biological pathways.
Latest Patents
Stuart McRae Allan holds a patent for "Cyclic diarylboron derivatives as NLRP3 inflammasome inhibitors." This patent discloses inhibitor compounds that are effective in treating diseases or conditions where interleukin 1β activity is implicated. The patent also details methods for synthesizing these compounds, along with pharmaceutical compositions that include them.
Career Highlights
Stuart is affiliated with The University of Manchester, where he engages in research that bridges the gap between chemistry and medicine. His work focuses on innovative solutions to complex health issues, showcasing his commitment to advancing medical science.
Collaborations
He collaborates with esteemed colleagues, including Sally Freeman and Alex George Baldwin, to further enhance the impact of his research and inventions.
Conclusion
Stuart McRae Allan's contributions to the field of pharmaceuticals through his innovative patents and collaborative efforts highlight his role as a key figure in advancing medical treatments. His work continues to inspire future innovations in the industry.